
Body Contouring For GLP-1 Patients: Evaluating Ultherapy PRIME
An estimated 22 million Americans using GLP-1 medications are now facing a new concern: loose skin on the body after rapid weight loss. This article evaluates Ultherapy PRIME’s recent FDA clearance for non-surgical body contouring, providing practitioners with evidence-based guidance on patient selection, combination therapies, and practice integration strategies.





